Peter Rahmer is See remarks at Relay Therapeutics, Inc. (RLAY). They have made 24 open-market trades across 1 company since 2023, most recently 2026-08-26.
CIK 0001959229
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 24 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| RLAY | 223,657 | $3.6M |
Shares reported on the most recent Form 4, priced at the 2026-08-28 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| RLAY | SELL · 10b5-1 | 2026-08-26 | 2026-08-28 | $20.03 | $90K | +1.7% | -4.8% | — |
| RLAY | SELL | 2026-07-28 | 2026-07-30 | $18.61 | $14K | +2.8% | -5.6% | — |
| RLAY | SELL · 10b5-1 | 2026-06-30 | 2026-07-02 | $19.09 | $955K | +4.6% | +0.6% | -3.3% |
| RLAY | SELL | 2026-04-28 | 2026-04-30 | $14.79 | $11K | +0.6% | +11.1% | +42.9% |
| RLAY | SELL | 2026-01-27 | 2026-01-29 | $7.71 | $100K | +16.8% | +27.1% | +62.9% |
| RLAY | SELL | 2025-10-28 | 2025-10-30 | $7.37 | $439K | -14.2% | +1.0% | +4.4% |
| RLAY | SELL | 2025-07-28 | 2025-07-30 | $3.68 | $121K | -8.5% | +1.1% | +111.8% |
| RLAY | SELL | 2025-04-28 | 2025-04-30 | $3.02 | $37K | -6.3% | -9.6% | +9.0% |
| RLAY | SELL | 2025-03-27 | 2025-03-31 | $2.84 | $701 | -14.0% | +29.1% | +34.1% |
| RLAY | SELL | 2025-01-28 | 2025-01-30 | $4.52 | $326K | -18.3% | -30.1% | -27.3% |
| RLAY | SELL · 10b5-1 | 2025-01-02 | 2025-01-06 | $4.27 | $691K | -2.0% | +5.3% | -54.9% |
| RLAY | SELL | 2024-12-27 | 2024-12-31 | $4.38 | $2K | +4.7% | +9.4% | -36.9% |
| RLAY | SELL | 2024-10-28 | 2024-10-30 | $6.06 | $10K | +7.9% | -17.7% | -19.1% |
| RLAY | SELL | 2024-09-27 | 2024-10-01 | $7.51 | $2K | +4.3% | -13.6% | -35.9% |
| RLAY | SELL · 10b5-1 | 2024-07-29 | 2024-07-31 | $8.33 | $694K | -20.1% | -16.7% | -27.6% |
| RLAY | SELL | 2024-06-27 | 2024-07-01 | $6.26 | $2K | +30.0% | +29.7% | +11.7% |
| RLAY | SELL · 10b5-1 | 2024-06-03 | 2024-06-05 | $6.65 | $941K | -5.1% | -14.9% | -13.4% |
| RLAY | SELL | 2024-04-29 | 2024-04-29 | $6.38 | $9K | -2.2% | -4.0% | +27.4% |
| RLAY | SELL | 2024-03-27 | 2024-03-29 | $7.70 | $2K | -16.9% | -20.6% | -24.1% |
| RLAY | SELL | 2024-01-29 | 2024-01-31 | $9.64 | $16K | +2.3% | +8.9% | -29.6% |
| RLAY | SELL | 2023-12-27 | 2023-12-29 | $11.51 | $3K | +5.7% | -7.7% | -22.9% |
| RLAY | SELL | 2023-10-30 | 2023-11-01 | $6.03 | $8K | +11.1% | +25.4% | +37.5% |
| RLAY | SELL | 2023-09-27 | 2023-09-29 | $8.38 | $2K | +6.2% | -25.6% | +35.4% |
| RLAY | SELL | 2023-07-28 | 2023-07-31 | $11.80 | $16K | -12.4% | -14.6% | -50.0% |
| RLAY | SELL | 2023-06-27 | 2023-06-28 | $12.12 | $3K | -7.3% | -6.4% | -36.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.